FDA INVESTIGATION HAS LED TO CHARGES AGAINST TWO INDIAN NATIONALS INVOLVED IN A TRANSNATIONAL COUNTERFEIT DRUG DISTRIBUTION SCHEME, WITH THE FDA ALLEGING THAT BETWEEN JULY 2023 AND APRIL 2024, SWAPNADIP ROY AND VICKY RAMANCHA OBTAINED COUNTERFEIT OZEMPIC FROM UNAUTHORIZED SOURCES